MARK EBERHARD: Open Payments
NPI 1760945877 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 46 payments from 13 companies in 2025. Trend: 2023 $683 · 2024 $741 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $190 |
| Lilly USA, LLC | 9 | $152 |
| AstraZeneca Pharmaceuticals LP | 5 | $96 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| Abbott Laboratories | 2 | $47 |
| Verona Pharma, Inc. | 2 | $35 |
| Exact Sciences Corporation | 1 | $33 |
| Amgen Inc. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Novo Nordisk Inc | 1 | $23 |
Products named: AIRSUPRA, MOUNJARO, VRAYLAR, LINZESS, FREESTYLE LIBRE 3, JARDIANCE, TRELEGY ELLIPTA, Ohtuvayre.
Industry payments across NY — which companies pay providers there.
